An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-20
DOI
10.3389/fmed.2021.630209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin-(1-7) and Angiotensin II in Human Plasma
- (2021) Mark C. Chappell et al. HYPERTENSION
- Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
- (2021) Jordana B Cohen et al. Lancet Respiratory Medicine
- Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics
- (2020) David Gurwitz DRUG DEVELOPMENT RESEARCH
- Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
- (2020) Yushun Wan et al. JOURNAL OF VIROLOGY
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- (2020) Renato D. Lopes et al. AMERICAN HEART JOURNAL
- COVID-19 with Different Severities: A Multicenter Study of Clinical Features
- (2020) Yun Feng et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
- (2020) Matthew J Cummings et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid repurposing of drugs for COVID-19
- (2020) R. Kiplin Guy et al. SCIENCE
- Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study
- (2020) Christopher M Petrilli et al. BMJ-British Medical Journal
- Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
- (2020) Juyi Li et al. JAMA Cardiology
- Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury
- (2020) Riccardo Sarzani et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality
- (2020) Emil L. Fosbøl et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19
- (2020) Jan Wysocki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial
- (2020) Giuseppe Mancia CARDIOVASCULAR RESEARCH
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Losartan Rescues Inflammation-Related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis
- (2019) Michael D Kim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease
- (2018) Jay Ramchand et al. PLoS One
- Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling
- (2016) Tomos E. Walters et al. EUROPACE
- The Effect of Endogenous Angiotensin II on Alveolar Fluid Clearance in Rats with Acute Lung Injury
- (2016) Jia Deng et al. Canadian Respiratory Journal
- Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats
- (2015) Jan Klimas et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
- (2014) M. Furuhashi et al. AMERICAN JOURNAL OF HYPERTENSION
- Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
- (2014) Zhen Zou et al. Nature Communications
- Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
- (2014) Penghui Yang et al. Scientific Reports
- Modulation of Transforming Growth Factor- Signaling and Extracellular Matrix Production in Myxomatous Mitral Valves by Angiotensin II Receptor Blockers
- (2012) A. Geirsson et al. CIRCULATION
- LPS-Stimulated Cytokine Production in Type I Cells Is Modulated by the Renin–Angiotensin System
- (2011) Mandi H. Wong et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Angiotensin receptor blockade attenuates cigarette smoke–induced lung injury and rescues lung architecture in mice
- (2011) Megan Podowski et al. JOURNAL OF CLINICAL INVESTIGATION
- Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model
- (2008) Moon Young Kim et al. JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search